Senti Biosciences (SNTI) Current Leases (2021 - 2025)
Senti Biosciences' quarterly Current Leases came in at $5.3 million in Q4 2025, up 14.7% year-on-year from $4.6 million in Q4 2024, and up 3.43% quarter-over-quarter from $5.2 million in Q3 2025.
Senti Biosciences has reported Current Leases for 5 years, with the latest figure at $5.3 million in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 14.7% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $5.3 million (up 14.7% YoY), and the FY2025 full-year result was $5.3 million, up 14.7% from the prior year.
- Current Leases for Q4 2025 stood at $5.3 million, up from $5.2 million in the prior quarter.
- The five-year high for Current Leases was $5.3 million in Q4 2025, with the low at $96000.0 in Q3 2023.
- Average Current Leases over 5 years is $3.2 million, with a median of $4.0 million recorded in 2023.
- Year-over-year, Current Leases sank 95.14% in 2024 and jumped 4711.0% in 2025.
- Tracing SNTI's Current Leases over 5 years: stood at $1.7 million in 2021, then advanced by 10.27% to $1.9 million in 2022, then jumped by 109.73% to $4.0 million in 2023, then grew by 15.28% to $4.6 million in 2024, then gained by 14.7% to $5.3 million in 2025.
- The last three Current Leases figures came in at $5.3 million (Q4 2025), $5.2 million (Q3 2025), and $5.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 4.65 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 4.03 Mn |
| Sep 30, 2023 | 96,000.00 |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.74 Mn |